June 2009 Volume 28 Number 24, pp 2305 - 2363
----------------------------------------------------------------------
Nature Reviews Goes Clinical!
In April 2009, Nature Clinical Practice Rheumatology was completely
redesigned and became Nature ReviewsRheumatology, bringing all the
qualities of thetop-ranked* life science review series to the
clinical sciences.
For more information visit:
http://links.ealert.nature.com/ctt?kn=12&m=33428363&r=MTc2ODI0Mjc1MwS2&b=2&j=NTE2NTAwOTIS1&mt=1&rt=0
*2007 Journal Citation Report (Thomson Reuters, 2008)
----------------------------------------------------------------------
Call for papers!
Submit your best work in the field of oncogenes, including mechanism
of activation, structure and function of encoded proteins; DNA and RNA
tumor viruses and all other aspects of structure and function.
Our online submission process is easy and can assist you in becoming
part of this distinguished journal. To learn about the benefits of
submitting your paper to Oncogene, visit
http://links.ealert.nature.com/ctt?kn=6&m=33428363&r=MTc2ODI0Mjc1MwS2&b=2&j=NTE2NTAwOTIS1&mt=1&rt=0
----------------------
REVIEW
----------------------
Kinase drug discovery approaches in chronic myeloproliferative disorders
C Kumar, A V Purandare, F Y Lee and M V Lorenzi
Abstract: http://links.ealert.nature.com/ctt?kn=16&m=33428363&r=MTc2ODI0Mjc1MwS2&b=2&j=NTE2NTAwOTIS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=11&m=33428363&r=MTc2ODI0Mjc1MwS2&b=2&j=NTE2NTAwOTIS1&mt=1&rt=0
----------------------
ORIGINAL ARTICLES
----------------------
Chk1 C-terminal regulatory phosphorylation mediates checkpoint activation by de-repression of Chk1 catalytic activity
M Walker, E J Black, V Oehler, D A Gillespie and M T Scott
Abstract: http://links.ealert.nature.com/ctt?kn=45&m=33428363&r=MTc2ODI0Mjc1MwS2&b=2&j=NTE2NTAwOTIS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=18&m=33428363&r=MTc2ODI0Mjc1MwS2&b=2&j=NTE2NTAwOTIS1&mt=1&rt=0
Blockade of Cripto binding to cell surface GRP78 inhibits oncogenic Cripto signaling via MAPK/PI3K and Smad2/3 pathways
J A Kelber, A D Panopoulos, G Shani, E C Booker, J C Belmonte, W W Vale and P C Gray
Abstract: http://links.ealert.nature.com/ctt?kn=9&m=33428363&r=MTc2ODI0Mjc1MwS2&b=2&j=NTE2NTAwOTIS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=5&m=33428363&r=MTc2ODI0Mjc1MwS2&b=2&j=NTE2NTAwOTIS1&mt=1&rt=0
Phosphoproteomic analysis of Syk kinase signaling in human cancer cells reveals its role in cell-cell adhesion
R M Larive, S Urbach, J Poncet, P Jouin, G Mascre, A Sahuquet, P H Mangeat, P J Coopman and N Bettache
Abstract: http://links.ealert.nature.com/ctt?kn=39&m=33428363&r=MTc2ODI0Mjc1MwS2&b=2&j=NTE2NTAwOTIS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=47&m=33428363&r=MTc2ODI0Mjc1MwS2&b=2&j=NTE2NTAwOTIS1&mt=1&rt=0
PUMA mediates EGFR tyrosine kinase inhibitor-induced apoptosis in head and neck cancer cells
Q Sun, L Ming, S M Thomas, Y Wang, Z G Chen, R L Ferris, J R Grandis, L Zhang and J Yu
Abstract: http://links.ealert.nature.com/ctt?kn=26&m=33428363&r=MTc2ODI0Mjc1MwS2&b=2&j=NTE2NTAwOTIS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=22&m=33428363&r=MTc2ODI0Mjc1MwS2&b=2&j=NTE2NTAwOTIS1&mt=1&rt=0
----------------------
SHORT COMMUNICATION
----------------------
Tie2-mediated multidrug resistance in malignant gliomas is associated with upregulation of ABC transporters
V Martin, J Xu, S K Pabbisetty, M M Alonso, D Liu, O-H Lee, J Gumin, K P Bhat, H Colman, F F Lang, J Fueyo and C Gomez-Manzano
Abstract: http://links.ealert.nature.com/ctt?kn=48&m=33428363&r=MTc2ODI0Mjc1MwS2&b=2&j=NTE2NTAwOTIS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=49&m=33428363&r=MTc2ODI0Mjc1MwS2&b=2&j=NTE2NTAwOTIS1&mt=1&rt=0
----------------------------------------------------------------------
Ensure your access
If you are unable to access the articles in this Table of Contents
e-alert, your library may not subscribe to this journal. Our online
recommendation form is a simple way to make your librarian aware that
this journal is valuable to your research.
Recommend now at
http://links.ealert.nature.com/ctt?kn=30&m=33428363&r=MTc2ODI0Mjc1MwS2&b=2&j=NTE2NTAwOTIS1&mt=1&rt=0
=====================================================================
You have been sent this Table of Contents Alert because you have opted in to receive it.
You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at:
http://links.ealert.nature.com/ctt?kn=20&m=33428363&r=MTc2ODI0Mjc1MwS2&b=2&j=NTE2NTAwOTIS1&mt=1&rt=0
(You will need to log in to be recognised as a nature.com registrant).
For further technical assistance, please contact our registration department:
registration@nature.com
For print subscription enquiries, please contact our subscription department:
subscriptions@nature.com
For other enquiries, please contact customer feedback department:
feedback@nature.com
Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA
Nature Publishing Group's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne - San Diego - San Francisco - Washington - New York - Boston
Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS.
© Copyright 2009 Nature Publishing Group
=====================================================================
